Universal Appoints New CFO Steven Diel
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 09 2026
0mins
Should l Buy UVV?
Source: seekingalpha
- Executive Appointment: Universal has announced the appointment of Steven Diel as the new Senior Vice President and CFO, effective April 1, aiming to strengthen financial management and strategic planning to tackle future market challenges.
- Previous Role: Before joining Universal, Diel served as Vice President and CFO of Universal Ingredients, bringing extensive industry experience that could enhance the company's financial stability and growth potential.
- Transition Plan: Current CFO Johan Kroner will remain as Senior Vice President until July 1, ensuring a smooth transition during the executive handover and maintaining operational continuity for the company.
- Market Reaction: While the new CFO's appointment may positively impact the company's financial strategy, the market remains cautious about Universal's growth expectations, reflecting concerns over the company's future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UVV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UVV
About UVV
Universal Corporation is a global agricultural company engaged in supplying products and solutions to meet its customers’ evolving needs and precise specifications. The Company is engaged in the leaf tobacco business and investing in the growth of its plant-based ingredients platform. It operates through two segments: Tobacco Operations and Ingredients Operations. The Tobacco Operations segment involves procuring and processing flue-cured, burley, dark air-cured, and oriental leaf tobacco for manufacturers of consumer tobacco products and performing related services. Through its Ingredients Operations segment, it procures raw materials globally and processes the raw materials through a variety of value-added manufacturing processes to produce specialty plant-based ingredients, including fruits, vegetables, botanical extracts, and flavorings for consumer-packaged goods manufacturers, retailers, and food and beverage companies. It operates in over 30 countries on five continents.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Universal Corporation Reports Q3 Earnings Miss Amid Tobacco Oversupply
- Earnings Miss: Universal Corporation reported Q3 EPS of $1.35, significantly below the expected $1.92, marking a 29.69% miss, which contributed to a 44.25% year-over-year decline in net income to $33.25 million, prompting a more than 10% drop in share price as investors reacted negatively to the disappointing results.
- Tobacco Sales Decline: The company acknowledged an oversupply in the tobacco market, with sales volumes falling approximately 8% in Q3, alongside increased inventory write-downs, as CEO Preston Wigner warned of a projected rise in flue-cured and burley crops by 25% and 45%, respectively, which will exacerbate market pressures.
- Diversification Losses: Universal's investment in a plant-based ingredients business has yet to yield results, as Q3 saw the segment swing to an operating loss due to rising fixed costs and soft consumer demand, highlighting the challenges faced during this transition and the resistance from the market.
- Liquidity Improvement: The company successfully upsized its revolving credit facility by $250 million and extended the maturity to December 2030, providing approximately $595 million available, which is crucial given the negative operating cash flow of -$58.04 million in Q3, thus offering support for future operations.
See More
Hospital and Medical Practitioners Stocks Decline
- Market Underperformance: On Tuesday, hospital and medical practitioners' stocks collectively fell by approximately 1.2%, indicating a decline in market confidence in the sector, which could negatively impact long-term investor expectations.
- AdaptHealth Leads Decline: AdaptHealth's stock plummeted by about 13.6%, making it the worst performer in the industry, suggesting potential operational or financial challenges that could affect its market share.
- Centene Pressured: Centene's stock decreased by approximately 3.5%, and although the drop is smaller, it still reflects market concerns regarding its future growth, potentially prompting investors to reassess their investment strategies.
- Industry Trend Warning: The overall decline in the healthcare sector may signal broader economic issues, prompting investors to monitor relevant policy changes and market dynamics to adjust their portfolios accordingly.
See More
Universal Corporation Q3 2026 Earnings Call Insights
- Financial Performance Overview: In Q3 2026, Universal Corporation reported consolidated revenue of $861.3 million, down from $937.2 million year-over-year, with operating income at $82 million and net income at $33.2 million, indicating performance challenges amid market pressures.
- Tobacco Segment Resilience: Despite transitioning to an oversupply environment, the Tobacco Operations segment generated $779.9 million in revenue, down from $853.9 million last year, yet maintained operating income at $84 million, demonstrating the company's stability in adversity.
- Ingredients Segment Pressure: The Ingredients Operations segment reported revenue of $81.3 million, slightly down from $83.3 million year-over-year, with an operating loss of $0.1 million, reflecting the impact of rising fixed costs and tariff pressures.
- Enhanced Liquidity: The company successfully upsized its senior unsecured credit facility by $250 million, increasing total liquidity to $917 million, significantly improving financial flexibility and supporting future market challenges.
See More
UNIVERSAL CORPORATION STOCK FALLS 7.5% FOLLOWING Q3 REPORT AND APPOINTMENT OF STEVEN DIEL AS CFO
Universal Corporation's Stock Performance: Universal Corporation's shares have decreased by 7.5% following the release of their Q3 results.
Leadership Change: The company has appointed Steven Diehl as the new Chief Financial Officer (CFO).
See More
Universal Appoints New CFO Steven Diel
- Executive Appointment: Universal has announced the appointment of Steven Diel as the new Senior Vice President and CFO, effective April 1, aiming to strengthen financial management and strategic planning to tackle future market challenges.
- Previous Role: Before joining Universal, Diel served as Vice President and CFO of Universal Ingredients, bringing extensive industry experience that could enhance the company's financial stability and growth potential.
- Transition Plan: Current CFO Johan Kroner will remain as Senior Vice President until July 1, ensuring a smooth transition during the executive handover and maintaining operational continuity for the company.
- Market Reaction: While the new CFO's appointment may positively impact the company's financial strategy, the market remains cautious about Universal's growth expectations, reflecting concerns over the company's future performance.
See More
Universal Corporation Q3 Earnings Miss Expectations
- Earnings Report Disappointment: Universal Corporation's Q3 Non-GAAP EPS of $1.35 misses expectations by $0.57, indicating pressure on profitability that could undermine investor confidence.
- Revenue Decline: The company reported revenue of $861.3 million, an 8.1% year-over-year decrease, falling short of expectations by $65.9 million, reflecting challenges from weak market demand and increased competition.
- Cautious Future Outlook: While Universal Corporation highlighted attractive yields during the investor conference, its conservative growth outlook may heighten investor concerns regarding long-term growth potential.
- Executive Changes: The appointment of a new CFO could introduce fresh financial strategies and management directions, yet the company must first navigate current financial challenges to restore market confidence.
See More
Universal Corporation Reports Q3 Earnings Miss Amid Tobacco Oversupply
- Earnings Miss: Universal Corporation reported Q3 EPS of $1.35, significantly below the expected $1.92, marking a 29.69% miss, which contributed to a 44.25% year-over-year decline in net income to $33.25 million, prompting a more than 10% drop in share price as investors reacted negatively to the disappointing results.
- Tobacco Sales Decline: The company acknowledged an oversupply in the tobacco market, with sales volumes falling approximately 8% in Q3, alongside increased inventory write-downs, as CEO Preston Wigner warned of a projected rise in flue-cured and burley crops by 25% and 45%, respectively, which will exacerbate market pressures.
- Diversification Losses: Universal's investment in a plant-based ingredients business has yet to yield results, as Q3 saw the segment swing to an operating loss due to rising fixed costs and soft consumer demand, highlighting the challenges faced during this transition and the resistance from the market.
- Liquidity Improvement: The company successfully upsized its revolving credit facility by $250 million and extended the maturity to December 2030, providing approximately $595 million available, which is crucial given the negative operating cash flow of -$58.04 million in Q3, thus offering support for future operations.
See More
Hospital and Medical Practitioners Stocks Decline
- Market Underperformance: On Tuesday, hospital and medical practitioners' stocks collectively fell by approximately 1.2%, indicating a decline in market confidence in the sector, which could negatively impact long-term investor expectations.
- AdaptHealth Leads Decline: AdaptHealth's stock plummeted by about 13.6%, making it the worst performer in the industry, suggesting potential operational or financial challenges that could affect its market share.
- Centene Pressured: Centene's stock decreased by approximately 3.5%, and although the drop is smaller, it still reflects market concerns regarding its future growth, potentially prompting investors to reassess their investment strategies.
- Industry Trend Warning: The overall decline in the healthcare sector may signal broader economic issues, prompting investors to monitor relevant policy changes and market dynamics to adjust their portfolios accordingly.
See More
Universal Corporation Q3 2026 Earnings Call Insights
- Financial Performance Overview: In Q3 2026, Universal Corporation reported consolidated revenue of $861.3 million, down from $937.2 million year-over-year, with operating income at $82 million and net income at $33.2 million, indicating performance challenges amid market pressures.
- Tobacco Segment Resilience: Despite transitioning to an oversupply environment, the Tobacco Operations segment generated $779.9 million in revenue, down from $853.9 million last year, yet maintained operating income at $84 million, demonstrating the company's stability in adversity.
- Ingredients Segment Pressure: The Ingredients Operations segment reported revenue of $81.3 million, slightly down from $83.3 million year-over-year, with an operating loss of $0.1 million, reflecting the impact of rising fixed costs and tariff pressures.
- Enhanced Liquidity: The company successfully upsized its senior unsecured credit facility by $250 million, increasing total liquidity to $917 million, significantly improving financial flexibility and supporting future market challenges.
See More
UNIVERSAL CORPORATION STOCK FALLS 7.5% FOLLOWING Q3 REPORT AND APPOINTMENT OF STEVEN DIEL AS CFO
Universal Corporation's Stock Performance: Universal Corporation's shares have decreased by 7.5% following the release of their Q3 results.
Leadership Change: The company has appointed Steven Diehl as the new Chief Financial Officer (CFO).
See More
Universal Appoints New CFO Steven Diel
- Executive Appointment: Universal has announced the appointment of Steven Diel as the new Senior Vice President and CFO, effective April 1, aiming to strengthen financial management and strategic planning to tackle future market challenges.
- Previous Role: Before joining Universal, Diel served as Vice President and CFO of Universal Ingredients, bringing extensive industry experience that could enhance the company's financial stability and growth potential.
- Transition Plan: Current CFO Johan Kroner will remain as Senior Vice President until July 1, ensuring a smooth transition during the executive handover and maintaining operational continuity for the company.
- Market Reaction: While the new CFO's appointment may positively impact the company's financial strategy, the market remains cautious about Universal's growth expectations, reflecting concerns over the company's future performance.
See More
Universal Corporation Q3 Earnings Miss Expectations
- Earnings Report Disappointment: Universal Corporation's Q3 Non-GAAP EPS of $1.35 misses expectations by $0.57, indicating pressure on profitability that could undermine investor confidence.
- Revenue Decline: The company reported revenue of $861.3 million, an 8.1% year-over-year decrease, falling short of expectations by $65.9 million, reflecting challenges from weak market demand and increased competition.
- Cautious Future Outlook: While Universal Corporation highlighted attractive yields during the investor conference, its conservative growth outlook may heighten investor concerns regarding long-term growth potential.
- Executive Changes: The appointment of a new CFO could introduce fresh financial strategies and management directions, yet the company must first navigate current financial challenges to restore market confidence.
See More
